MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes
Marco Witkowski(Cleveland Clinic), Ursula Rauch(Charité - Universitätsmedizin Berlin), Carsten Skurk(Universität Hamburg), Diethelm Tschoepe(Heart and Diabetes Center North Rhine-Westphalia), Bernd Stratmann(Heart and Diabetes Center North Rhine-Westphalia), Julian Friebel(Feuerwehr Dortmund), Mario Witkowski(Leibniz Association), Daniel Steffens(The University of Sydney), Ulf Landmesser(Deutsches Herzzentrum der Charité), Termeh Tabaraie(Johannes Gutenberg University Mainz), Andrea Dörner(Charité - Universitätsmedizin Berlin)
Cited by 30
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k